Does Classic CAH Affect Height and Growth in Children?

Many parents wonder if their child will be shorter than average because of Classic simple-virilizing Congenital Adrenal Hyperplasia (CAH) or the daily medications used to treat it. The short answer is that while many children with CAH achieve an adult height within the normal range for the general population, on average, they tend to be slightly shorter than their genetic target (the height expected based on their parents’ heights) ^[1][2]. Reaching your child’s best possible height requires a very careful, ongoing balancing act with their daily medication ^[3].

The Treatment Balancing Act

In classic simple-virilizing CAH, the body cannot make enough cortisol and instead overproduces androgens (sex hormones naturally present in all people, but produced in excess in CAH) ^[4]. Managing the condition means giving enough glucocorticoid medication (like hydrocortisone, which replaces the missing cortisol) to bring down high androgen levels ^[4]. Both the disease itself and the medication used to treat it can impact growth:

• Undertreatment (Too little medication): If the dose is too low, the adrenal glands continue to pump out excess androgens ^[4]. These hormones can cause young children to grow very quickly at first—making them taller than their peers in early childhood ^[2][5]. However, excess androgens also cause the growth plates (the areas of developing cartilage at the ends of long bones) to mature and close too early ^[6][5]. Once the growth plates close, a person cannot gain any more linear height, which can result in a shorter final adult height ^[7].
• Overtreatment (Too much medication): Because excess androgens cause early bone fusion, it might seem logical to use high doses of glucocorticoids to completely suppress them. However, chronic exposure to more glucocorticoid medication than the body naturally needs for replacement can suppress a child’s growth rate and prevent them from growing tall enough ^[4][8].

The goal of treatment is not to suppress every single androgen hormone down to zero. Instead, doctors aim to provide just enough medication to control the androgens without causing the side effects of steroid overexposure ^[4].

IMPORTANT SAFETY WARNING: Never stop or reduce your child’s routine glucocorticoid medication to try to improve their height. Doing so can cause a life-threatening adrenal crisis. Always follow your endocrinologist’s prescribed sick-day rules (stress dosing) when your child is ill, feverish, or injured ^[9].

How Growth Patterns May Differ

Children with CAH sometimes experience a different growth pattern than children without the condition. Even with treatment, they might grow slightly faster than expected before puberty, and then experience a smaller or less noticeable “growth spurt” during puberty ^[2][1]. While this pattern can occur in treated CAH, sudden rapid growth, early development of pubic hair or body odor, or new acne are not automatically “normal” and can be signs of undertreatment or early puberty that require evaluation by your care team ^[7].

Monitoring for Success

To safely navigate this balancing act, your pediatric endocrinologist will closely monitor several things:

• Physical Growth: One of the most important parts of monitoring is how your child is growing ^[3][10]. The doctor will measure your child’s height, weight, and growth velocity (how fast they are growing over time), along with blood pressure and signs of puberty.
• Bone Age: A bone age is an X-ray of the left hand and wrist used to see how quickly your child’s skeleton is maturing compared to their chronological age ^[10]. If the bone age is advancing much faster than their actual age, it gives the endocrinologist important information to decide if a medication adjustment or further evaluation is needed ^[1].
• Hormone Levels: Blood tests to measure hormones like 17-OHP, androstenedione, and testosterone give the doctor a snapshot of adrenal gland activity ^[11]. Because hormone levels fluctuate throughout the day, the timing of the blood draw relative to when the medication was given is crucial ^[12]. The endocrinologist may accept a 17-OHP result that is higher than the standard “normal” range because fully suppressing it might require too much glucocorticoid medication ^[11].

Adjusting the medication dose is a normal and expected part of managing CAH as your child grows.